Advertisement
Advertisement
U.S. Markets open in 1 hr 24 mins
Advertisement
Advertisement
Advertisement
Advertisement

Olaplex Holdings, Inc. (OLPX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
24.85+0.44 (+1.80%)
At close: 4:00PM EDT
24.75 -0.10 (-0.40%)
Pre-Market: 07:00AM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close24.41
Open24.41
Bid24.65 x 800
Ask24.95 x 800
Day's Range24.41 - 24.95
52 Week Range22.84 - 27.74
Volume630,636
Avg. Volume7,136,358
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    OLAPLEX Announces Exercise of Over-Allotment Option in Initial Public Offering

    SANTA BARBARA, Calif., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (“OLAPLEX”) announced that the underwriters of its previously announced initial public offering of common stock fully exercised their option to purchase an additional 11,055,000 shares of common stock at the public offering price of $21.00 per share, less underwriting discounts and commissions. The exercise of the over-allotment closed on October 8, 2021. The shares were offered by certain of OLAPLEX’s existing stock

  • Investopedia

    OLPX went public at $21 a share on Sept. 30, 2021

    Olaplex, a luxury haircare company, went public on the Nasdaq under the ticker OLPX for $21 a share on Sept. 30, 2021.

  • Benzinga

    51 Biggest Movers From Yesterday

    Gainers Superior Drilling Products, Inc. (NYSE: SDPI) shares rose 60.6% to close at $1.75 on Thursday after jumping over 23% on Wednesday. The company, last month, reported Q2 earnings of $0.00 per share on sales of $3.40 million. Progenity, Inc. (NASDAQ: PROG) jumped 40.7% to close at $1.52 after jumping around 22% on Wednesday. Progenity recently announced the USPTO has issued U.S. Patent No. 11,112,403 for assessment of preeclampsia using assays for free and dissociated placental growth facto

Advertisement
Advertisement